Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatmentsRosanna Coppo, Agnieszka Perkowska‐Ptasińska, Sigrid Lunberg et al.|Kidney International|2014Cited by 506
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) updateRosanna Coppo, Raffaella Cravero, Graziella D’Arrigo et al.|Nephrology Dialysis Transplantation|2018Cited by 112
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathyFrancesco Paolo Schena, Harm Peters, Vito Walter Anelli et al.|Kidney International|2020Cited by 110
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsySean J. Barbour, Fernanda Carvalho, Rosanna Coppo et al.|Kidney International|2022Cited by 82
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction ToolSean J. Barbour, Lucia Del Vecchio, Mark Canney et al.|Kidney International|2020Cited by 54